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Abstract
Background:  Leptin acts not only on hypothalamic centers to control food intake but has
additional functions in peripheral tissues, e.g. inhibition of insulin secretion from pancreatic islets.
The leptin receptor (LEPRb) is a class I cytokine receptor that mediates activation of STAT
transcription factors. In this study, we characterise the regulation of inflammation-related genes by
leptin in insulinoma cells and compare the effect of transcriptional regulation by leptin with that of
other cytokines.
Results: We have used RINm5F insulinoma cells as a model system for a peripheral target cell of
leptin. Six transcripts encoding inflammation-related proteins were found to be upregulated by
activation of LEPRb, namely lipocalin-2, pancreatitis-associated protein, preprotachykinin-1,
fibrinogen-β, tissue-type plasminogen activator (tPA) and manganese-dependent superoxide
dismutase (MnSOD). Four of these transcripts (fibrinogen-β, lipocalin-2, tPA, MnSOD) were also
induced by the proinflammatory cytokine interleukin-1β (IL-1β). Interferon-γ alone had no effect
on the leptin-induced transcripts but enhanced the upregulation by IL-1β of lipocalin-2, tPA and
MnSOD mRNA levels. Experiments with LEPRb point mutants revealed that the upregulation of
the inflammation-related genes depended on the presence of tyrosine-1138 which mediates the
activation of the transcription factors STAT1 and STAT3. Reporter gene assays showed that leptin
induced the expression of preprotachykinin-1 and lipocalin-2 on the level of promoter regulation.
Finally, leptin treatment increased caspase 3-like proteolytic activity in RINm5F cells.
Conclusion: The present data show that leptin induces a cytokine-like transcriptional response in
RINm5F cells, consistent with the proposed function of leptin as a modulator of immune and
inflammatory responses.
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Background
Leptin is a cytokine which is secreted predominantly by
white adipose tissue and exerts its effects on appetite and
thermogenesis on centers located in the hypothalamus
[1]. In addition to these well defined central actions, it has
become clear that leptin also has important peripheral
effects, including the regulation of the immune system
and the modulation of insulin secretion from the pan-
creas [2-4]. The requirement of leptin for a normal
immune response has been characterised in detail in vari-
ous animal models of autoimmune diseases and experi-
mentally induced inflammation [5,6]. This
proinflammatory effect of leptin is at least partially medi-
ated by its direct action on T-lymphocytes, although mac-
rophages and natural killer (NK) cells also appear to be
responsive to leptin [5-7].
Two main signalling pathways have been proposed to
mediate the inhibitory effect of leptin on insulin secre-
tion. Firstly, leptin causes the PI-3 kinase-dependent acti-
vation of phosphodiesterase 3B (PDE3B) and subsequent
reduction of intracellular cAMP levels [8]. Secondly, lep-
tin activates ATP-sensitive K+  channels on β-cells and
thereby antagonises depolarisation required for insulin
secretion [9]. These are both unusual pathways, consider-
ing that the leptin receptor (LEPR) belongs to the class I
cytokine receptor family and transmits signals mainly via
the JAK/STAT (Janus kinase/signal transducer and activa-
tor of transcription) pathway [10]. LEPR exists in several
splicing variants, the longest one (LEPRb) being the only
one capable of activating JAK/STAT signalling [11,12]. The
effect of leptin on β-cells clearly depends on the presence
of the long splicing variant of the leptin receptor (LEPRb),
because leptin does not inhibit insulin secretion from
islets isolated from db/db mice which harbour a splice site
mutation that specifically affects expression of LEPRb
[13]. Ligand binding to LEPRb results in trans-autophos-
phorylation and thereby activation of the receptor-associ-
ated tyrosine kinase JAK2 and subsequent recruitment
and activation of STAT factors to phosphorylated tyrosine
residues in the cytoplasmic part of LEPRb [10,14]. In rat
islet cells and in rodent insulinoma cell lines (RINm5F,
MIN6), leptin has been shown to stimulate tyrosyl phos-
phorylation of STAT1, STAT3, STAT5 and dual phosphor-
ylation of the MAP kinases ERK1/2 [15-18]. We have
recently shown that each of the three conserved tyrosine
residues in murine LEPRb exhibits different signalling
capacities in the insulinoma cell line HIT-T15 [18].
Tyr985 mediated leptin-induced activation of extracellu-
lar signal-regulated kinases 1 and 2 (ERK1/2), Tyr1077
induced tyrosyl phosphorylation of STAT5, and Tyr1138
was capable of activating STAT1, STAT3, and STAT5.
Although STAT factors are well known to regulate tran-
scription, the range of transcriptional targets responsive to
leptin stimulation of pancreatic β-cells is not well charac-
terised [19].
In the present study we used rat RINm5F insulinoma cells
as a model system to study the changes in gene expression
that leptin elicits in β-cells and to characterise the signal-
ling pathway(s) by which the transciptional effects of lep-
tin are mediated. In particular, we show that several
inflammation-related genes were upregulated by leptin.
Notably, some of these mRNAs were also induced by IL-
1β, a pro-inflammatory cytokine thought to play a major
role in β-cell destruction in type 1 diabetes mellitus. These
data provide the first characterisation of leptin's effects on
gene expression in a non-neuronal cell type.
Results
Identification of leptin-induced genes in RINm5F cells
We have previously employed RINm5F cells ectopically
expressing LEPRb to characterise leptin signal transduc-
tion in an insulin-producing cell line [18]. In order to
identify genes regulated by leptin in pancreatic β-cells, we
compared gene expression in leptin-stimulated and non-
stimulated RINm5F cells by differential hybridisation of
high-density filter arrays containing 27,648 non-redun-
dant rat cDNAs. From 33 transcripts that showed a strong
differential signal after 16 h of leptin treatment, we
selected 13 for further expression analysis by Northern
blot hybridisation. Table 1 lists 8 transcripts that were
confirmed to be upregulated by leptin. Five transcripts
were identified as false positives (see Additional file 1 for
the complete list).
In this study we focus on those genes potentially related
to inflammatory processes. Four transcripts encode
secreted acute phase proteins: fibrinogen-β, tissue-type
plasminogen activator (tPA), pancreatitis-associated pro-
tein (PAP1), and lipocalin-2 [20]. Preprotachykinin-1 is
the precursor of substance P, a mediator of neurogenic
inflammation [21]. In addition, the mitochondrial
enzyme manganese-dependent superoxide dismutase
(MnSOD) has also been classified as an "acute phase pro-
tein" because it is upregulated in many inflammatory con-
ditions [22].
Costimulatory effects of IL-1β and leptin
Considering that interleukin-1β (IL-1β) is an important
inflammatory mediator in pancreatic β-cells, we asked
whether leptin and IL-1β had overlapping effects on the
expression of inflammation-related genes. Therefore,
RINm5F cells were stimulated with IL-1β, leptin, or a
combination of leptin and IL-1β for different time peri-
ods, and mRNA levels of specific transcripts were analysed
by Northern blotting (Figure 1). As controls, we used
probes for iNOS, which is known to be induced by IL-1β,
and ribosomal protein L4 (RPL4) as a loading control.BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
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According to the different time courses of leptin-induced
upregulation, Northern blot analysis allowed us to distin-
guish immediate early (fibrinogen-β), delayed early
(PAP1) and late target genes (lipocalin-2, preprotachyki-
nin, tPA, MnSOD, and phosphatidate phosphohydrolase
2a/PPAP2A), which had their expression maxima at 1–3
h, 7 h and 16 h of leptin stimulation, respectively. Con-
cerning the effect of IL-1β, mRNA levels for fibrinogen-β,
tPA, lipocalin2, MnSOD and PPAP2A were found to be
upregulated by IL-1β alone. Among them, lipocalin2 and
MnSOD were more strongly induced by IL1β than by lep-
tin. As expected, iNOS mRNA was induced by IL-1β but
not by leptin. Costimulation with IL1β and leptin
revealed synergistic effects of both cytokines on the
expression of fibrinogen-β, lipocalin-2 and MnSOD, i.e.
the effect of costimulation exceeded the added effects of
each cytokine.
Comparison of leptin and IFNγ
It is well known that IL-1β and IFNγ synergistically regu-
late inflammation-related genes in pancreatic β-cells [23].
Since both leptin and IFNγ modulate gene expression by
activating the JAK/STAT pathway, we compared the effects
of these cytokines on the activation of STAT factors in the
RINm5F cell line. As we have previously reported [16],
leptin induced tyrosyl phosphorylation of both STAT3
and STAT1 (Figure 2). In contrast, IFNγ rather selectively
activated STAT1. Although in this direct comparison IFNγ
elicited a stronger tyrosyl phosphorylation of STAT1, this
result hints to the possibility that both cytokines have par-
tially overlapping effects on gene expression in RINm5F
cells.
Next we analysed the effects of leptin and IFNγ on the
expression of the inflammation-related transcripts identi-
fied in the present study. RINm5F cells were stimulated
with leptin or IFNγ either alone or in combination with
IL-1β, and transcript levels were determined by Northern
blot hybridisation. A probe for IFNγ-regulated factor 1
(IRF1) was included as a positive control for the action of
IFNγ. As shown in Figure 3, IFNγ alone did not upregulate
the transcripts that were induced by leptin. On the other
hand, IRF1 mRNA levels were not affected by leptin. These
results show that leptin and IFNγ differentially regulate
the expression of inflammation-related genes in RINm5F
insulinoma cells, probably because the cytokines act via
different STAT factors. Interestingly, similar to leptin, IFNγ
enhanced the IL-1β-induced upregulation of the mRNAs
for tPA, lipocalin-2 and MnSOD.
Requirement of Tyr-1138 in LEPRb for induction of 
inflammation-related genes
Next, we asked which signalling pathway might be
involved in the induction of the inflammation-related
genes by leptin. To determine the role of the three intrac-
ellular tyrosine residues (Tyr985, Tyr1077, Tyr1138) in
LEPRb-mediated activation of gene expression, we gener-
ated RINm5F cell lines that stably express LEPRb point
mutants in which phenylalanines replace two of the three
tyrosines, or the triple mutant. Leptin binding assays veri-
fied that all LEPRb constructs were expressed at the cell
surface and differed by less than 2.2-fold in leptin binding
(surface binding sites of mutant receptors relative to the
wild type receptor: FFY, 1.10 ± 0.05; FYF 1.4 ± 0.06; YFF,
2.01 ± 0.13; FFF, 2.13 ± 0.47; for designations of the
LEPRb mutants see Figure 4).
To characterise the signalling potential of these cells, we
analyzed the leptin-induced phosphorylation of STAT fac-
tors and of ERK1/2 by Western blotting with activation
state-specific antibodies (Figure 4). The results show that
the full activation of STAT1 and STAT3 required the pres-
ence of Tyr1138, whereas the phosphorylation of STAT5
was mediated equally well by Tyr1077 and Tyr1138. The
Table 1: List of transcripts upregulated by 16 h-leptin treatment in RINm5F cells
Signal intensities†
Gene symbol* GenBank Accession. UniGene mock leptin Fold induction by 
leptin
Phosphatidate phosphohydrolase 2a Ppap2a AI555126 Rn.61687 0.3 2.4 8.9
Regulator of G-protein signaling 4 Rgs4 AI502324‡ Rn.11065 3.2 16.9 5.2‡
Preprotachykinin 1 Tac1 AA818532 Rn.1920 44.6 188.2 4.2
Fibrinogen, beta polypeptide Fgb AI059690§ Rn.11416 3.0 11.4 3.8§
Plasminogen activator, tissue-type (tPA) Plat AA875008 Rn.107102 2.3 7.7 3.3
Lipocalin 2 Lcn2 AI137617 Rn.11303 2.7 8.7 3.2
Pancreatitis-associated protein (PAP1) Pap AA998280 Rn.9727 1.9 5.5 2.9
superoxide dismutase 2 (MnSOD) Sod2 AI029806 Rn.10488 17.1 48.3 2.8
* Official gene symbol in the Rat Genome Database
† Phosphoimager evaluation of filter array hybridization (relative units corrected to background and normalized to β actin
‡ Representative of four different Rgs4 cDNA clones (ratios: 5.2, 2.9, 2.8 and 2.4).
§ Representative of two different fibrinogen-β cDNA clones (ratios: 3.8 and 2.8).BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
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major part of ERK phosphorylation was dependent on the
membrane-proximal tyrosine residue (Tyr985). These
findings are in agreement with results that we have previ-
ously obtained in transiently transfected HIT-T15 insuli-
noma cells [18]. Intriguingly, a residual phosphorylation
of STAT factors and of ERK1/2 was detectable even when
all intracellular LEPRb tyrosine residues had been
exchanged for phenylalanine. This cannot be explained by
the action of endogenous LEPRb since neither the paren-
tal RINm5F cells nor control cells that were infected with
the empty vector showed detectable effects of leptin (data
not shown).
These cell lines were now used to study the capacity of the
LEPRb point mutants to upregulate mRNA levels of the
leptin target genes identified in this work. As shown in
Figure 5, induction by leptin depended on the presence of
Tyr1138, suggesting that the transcription of these genes is
regulated by STAT3 and/or STAT1. Consistent with the
tyrosine-independent activation of STAT3 detected by
Western blotting (Figure 4), weak leptin effects were also
observed in the cell lines expressing LEPRb-YFF or LEPRb-
FYF. However, the degree of induction by these constructs
did not exceed that of the triple mutant (FFF). Interest-
ingly, transcript levels were always higher in cells express-
ing LEPRb-FFY compared to wild type LEPRb, consistent
with a role for Tyr985 and Tyr1077 in the negative regula-
tion of leptin signalling [24,28].
Leptin controls preprotachykinin-1 and lipocalin-2 gene 
expression at the level of promoter regulation
To substantiate the hypothesis that leptin controls the
expression of inflammation-related genes by way of tran-
scriptional regulation, we decided to determine the effect
of leptin on promoter activity. We selected two rat genes
whose promoters had not previously been analysed for
Activation of STAT1 and STAT3 by leptin and IFNγ Figure 2
Activation of STAT1 and STAT3 by leptin and IFNγ. 
RINm5F cells stably expressing LEPRb were stimulated with 
the indicated concentrations of IFNγ or leptin for 15 min. 
Tyrosyl phosphorylation of STAT1 and STAT3 was deter-
mined by Western blot analysis of total cellular lysates with 
activation state-specific antibodies. The two bands reacting 
with the pTyr(705)-STAT1 antibody represent the splice var-
iants STAT1α (91kD) and STAT1β (84 kD). The lower band 
detected by the STAT3 antibodies is probably the splice vari-
ant STAT3β. Total STAT3 immunoreactivity is shown as a 
control.
Effects of leptin and IL-1β on inflammation-related transcripts  in RINm5F insulinoma cells Figure 1
Effects of leptin and IL-1β on inflammation-related 
transcripts in RINm5F insulinoma cells. RINm5F cells 
stably expressing LEPRb were treated with leptin (100 ng/
ml), IL-1β (50 u/ml), or a combination of both for the times 
indicated (1, 3, 7 or 16 h). Total RNA was isolated and sub-
jected to Northern blot analysis with cDNA probes identi-
fied by differential hybridisation of the cDNA array (upper 6 
panels, see table 1). iNOS and RPL4 serve as controls for an 
IL-1β-regulated mRNA and an unregulated mRNA, respec-
tively. Gene symbols are shown in italics. A sample of 
degraded RNA on one of the blots is marked with an x.BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
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regulation by STAT factors, Lcn2 (encoding lipocalin-2)
and Tac1 (preprotachykinin-1). As in our previous studies
[18], we used HIT-T15 hamster insulinoma cells for the
promoter assays because RINm5F cells were only poorly
transfected in transient assays. The results of the luciferase
assays are presented in Figure 6 and show clearly that both
the Lcn2 and the Tac1 promoter are regulated by leptin.
Consistent with the Northern blot results, promoter
induction depended on the presence of Tyr1138 in
LEPRb, supporting the hypothesis that STAT1 and/or
STAT3 are involved. Also in agreement with the Northern
blot data, Lcn2  promoter activity was very low in the
absence of leptin and was strongly induced by leptin,
whereas the Tac1  promoter showed considerable basal
activity in the absence of a stimulus. These data indicate
that leptin upregulates expression of lipocalin-2 and pre-
protachykinin-1 by control of transcription.
To address the question whether the regulation of these
promoters by leptin was a specific feature of insulinoma
cells, we took advantage of a LEPRb-expressing PC-12
pheochromocytoma cell line that was established in a pre-
vious study [25]. In this cell line, the effect of leptin on tar-
get gene promoters was found to be enhanced by
simultaneous treatment with forskolin. Forskolin is a
nonspecific activator of adenylate cyclases and enhances
intracellular levels of cAMP. Similar to the results
obtained in HIT-T15 cells transfected with wild type
LEPRb, leptin induced both the Tac1 and the Lcn2 pro-
moter in the PC-12 cell line (Figure 7). The weaker effect
of leptin as compared to the HIT-T15 cells is likely due to
the fact that the PC-12 cells were not kept serum-free dur-
ing treatment with leptin and/or forskolin, in order to
avoid differentiation of the cells. Treatment with forskolin
further enhanced the effect of leptin on both promoters,
Signalling capacity of RINm5F cells expressing LEPRb point  mutants Figure 4
Signalling capacity of RINm5F cells expressing 
LEPRb point mutants. RINm5F cells stably expressing the 
wild type LEPRb (YYY) or the indicated LEPRb tyrosine/phe-
nylalanine mutants were treated with 100 ng/ml leptin (L) or 
vehicle (∅) for 15 min before total cell lysates were pre-
pared. Leptin-induced phosphorylation of downstream signal-
ling molecules was assayed by Western blotting and 
immunodetection with phospho-specific antibodies. Effects of leptin and IFNγ on inflammation-related transcripts Figure 3
Effects of leptin and IFNγ on inflammation-related 
transcripts. RINm5F cells were treated with the indicated 
cytokines (100 ng/ml leptin; 50 u/ml IL-1β; 25 ng/ml IFNγ) or 
combinations thereof for 3 h or 16 h before total RNA was 
isolated. mRNA levels of the indicated genes were assessed 
by Northern blot hybridisation. GAPDH was used as a con-
trol. The RNAs from leptin and/or IL-1 β treated cells were 
obtained in an experiment independent from that shown in 
Figure 1. A sample of partially degraded RNA on one of the 
blots is marked with an x.BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
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as previously observed for other leptin-regulated promot-
ers in this cell line (proopiomelanocortin, neuropeptide Y
and PAP [26]).
Leptin increases caspase-like proteolytic activity in 
RINm5F cells
To assess a possible cytotoxic effect of leptin on insulin-
producing cells, we determined the effect of leptin treat-
ment on the enzymatic activity of caspase 3 (and caspase
3-like proteases) as a key player in apoptosis induction.
Exposure of RINm5F-LEPRb cells to leptin led to caspase
3 activation in a dose-dependent manner (Figure 8). Co-
administration of leptin with IL-1β revealed an additive
effect of the cytokines. Leptin did not alter caspase activity
in untransfected RINm5F cells (data not shown), indicat-
ing that the effect depended on the presence of LEPRb. As
a positive control, the cells were also exposed to a mix of
IL-1β and IFNγ which is known to be proapoptotic for
RINm5F cells [27]. In this direct comparison, the combi-
nation of IL-1β (50 u/ml) and IFNγ (50 ng/ml) resulted in
Regulation of Lcn2 and Tac1 promoter by LEPRb mutants Figure 6
Regulation of Lcn2 and Tac1 promoter by LEPRb 
mutants. HIT-T15 hamster insulinoma cells were transiently 
transfected with luciferase constructs driven by the rat Tac1 
promoter or the rat Lcn2 promoter, along with the indicated 
LEPRb expression plasmids. Twenty-four hours after trans-
fection, the cells were treated with 100 ng/ml leptin or vehi-
cle for 24 hours in serum-free medium. Luciferase activities 
were determined from duplicate wells and data were nor-
malised to β-galactosidase activities. Data are expressed as 
fold stimulation by leptin relative to unstimulated cells. Bars 
reflect means +/- SD of three independent experiments 
(except for FFY in the upper panel which is the mean of two).
Regulation of leptin target gene expression by LEPRb tyro- sine mutants Figure 5
Regulation of leptin target gene expression by LEPRb 
tyrosine mutants. RINm5F cells expressing the indicated 
LEPRb tyrosine mutants were treated with 100 ng/ml leptin 
(L) or vehicle (∅) for 16 h. Northern blots were hybridised 
with the indicated cDNA probes.BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
Page 7 of 12
(page number not for citation purposes)
a stronger induction of caspase activity than IL-1β (50 u/
ml) plus leptin (100 ng/ml).
Discussion
To gain insight into the gene regulatory effects of leptin
that may contribute to its action on body weight regula-
tion, screens for the identification of leptin-regulated
genes have previously been performed in neuronal cell
lines overexpressing LEPRb [28,29]. Here we have used
the insulin-producing cell line RINm5F as a model system
to characterise the transcriptional effects of leptin in pan-
creatic β-cells, one of the peripheral target cells of leptin.
A striking result of this screen is that leptin induces the
expression of several genes related to inflammatory condi-
tions, including genes encoding acute phase response pro-
teins (tPA, fibrinogen-β, lipocalin-2, PAP1),
preprotachykinin and MnSOD. Moreover, some of these
leptin-induced transcripts were also induced by IL-1β,
which is considered to be the most cytotoxic cytokine for
β-cells [30,31]. These results reflect the molecular nature
of leptin as a cytokine and are consistent with the hypoth-
esis that high levels of leptin may play a role in the low-
grade inflammatory state associated with obesity [32].
What might be the role of these inflammation-related pro-
teins in pancreatic islets? Of the genes listed in table 1,
only Sod2 (encoding MnSOD) has been functionally stud-
ied in insulin-producing cells. Sod2 is strongly induced in
many cells, including RINm5F, by IL-1β via binding of
NFκB to specific promoter elements [33]. Oxygen free rad-
icals are generated in cytokine-stimulated β-cells, and
overexpression of MnSOD, which inactivates mitochon-
drially derived oxygen free radicals, can prevent cytokine-
induced apoptosis of β-cells [34-36]. Thus, upregulation
of MnSOD by leptin is likely to have a protective effect on
β-cells.
The role of the secreted acute phase proteins in β-cell
inflammation has not yet been directly addressed. The
product of the Pap gene (also known as PAP1 or Reg-2 in
Leptin induces caspase activity in RINm5F cells Figure 8
Leptin induces caspase activity in RINm5F cells. 
LEPRb-expressing RINm5F cells were exposed to the indi-
cated concentrations of leptin for 48 h, alone (open bars) or 
in combination with 50 u/ml IL-1β (hatched). Alternatively, 
cells were treated with a mix of 50 u/ml IL-1β and 50 ng/ml 
IFNγ. Caspase activity was determined in total cell lysates as 
the sequence-specific cleavage of a proluminescent DEVD-
aminoluciferin substrate. Data are expressed as fold stimula-
tion by the cytokine treatment relative to unstimulated cells. 
Bars reflect means +/- SD of 4 independent experiments. * P 
< 0.05, treated vs. untreated. The effect of 50 u/ml IL-1β and 
50 ng/ml IFNγ was not significantly greater than that of 50 u/
ml IL-1β plus 100 ng/ml leptin (P = 0.058)
Synergistic regulation of Lcn2 and Tac1 promoter activities by  leptin and forskolin in PC-12 pheochromocytoma cells Figure 7
Synergistic regulation of Lcn2 and Tac1 promoter 
activities by leptin and forskolin in PC-12 pheochro-
mocytoma cells. PC-12 cells stably expressing LEPRb were 
transiently transfected with the Tac1 or Lcn2 reporter gene 
constructs. Cells were left untreated or treated with leptin 
(100 ng/ml) and/or forskolin (10 µg/ml) for 24 hours before 
lysis. Luciferase activities were determined from duplicate 
wells and data were normalised to β-galactosidase activities. 
Data are expressed as fold stimulation by the treatment rela-
tive to unstimulated cells. Results are means +/- SD of three 
(Tac1 promoter) or four (Lcn2-promoter) independent 
experiments.BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
Page 8 of 12
(page number not for citation purposes)
rat or Reg3β in mouse) has been designated "pancreatitis-
associated protein" (PAP) because of its increased expres-
sion in rat pancreatic acinar cells in acute pancreatitis [37].
PAP1 belongs to a family of small secretory proteins that
are related to REG1. The gene name Reg1 refers to regen-
erating pancreatic islets following partial pancreatectomy,
where transcripts of Reg1 are significantly induced [38].
The REG1 protein is thought to act on pancreatic β-cells as
an autocrine and/or paracrine factor and has been demon-
strated to induce proliferation of β-cells and thereby to
ameliorate the diabetes of 90% depancreatised rats and
mice [39]. It is not known whether other members of the
REG family share this ability, but PAP1 has been shown to
act as an auto/paracrine neurotrophic factor on motoneu-
rons [40]. Furthermore, PAP1 has anti-inflammatory
effects in pancreatitis and inflammatory bowel disease
[41], suggesting that it may also protect β-cells in islet
inflammation. Interestingly, the PAP gene was found to
be overexpressed in islets from a patient with recent-onset
type 1 diabetes [42], indicating that its upregulation in
islet inflammation is not restricted to rodents.
Lipocalin-2 (also known as 24p3, neutrophil gelatinase-
associated lipocalin NGAL, siderocalin, uterocalin, super-
inducible protein 24) has been identified as a very highly
regulated transcript in many inflammatory conditions
[43]. Lipocalin-2 sequesters bacterial siderophores and is
a bacteriostatic agent contributing to the innate immune
response [44]. Furthermore, the iron-free lipocalin-2 apo-
protein can induce apoptosis of several cell types, includ-
ing leukocytes, whereas iron-containing holo lipocalin-2
can prevent apoptosis [45,46]. The effect of lipocalin-2 on
pancreatic β-cells has not yet been studied.
Fibrinogen-β and tPA are classical acute phase plasma
proteins that are predominately expressed in the liver
[20]. It is unlikely that the enhanced expression of these
proteins in pancreatic islets contributes significantly to
their blood level, but local effects on fibrogenesis or
fibrolysis may occur in insulitis. Similarly, the physiolog-
ical significance of preprotachykinin expression is not
clear. Preprotachykinin-1 is the precursor of substance P,
a mediator of neurogenic inflammation in inflammatory
diseases of the respiratory, gastrointestinal, and muscu-
loskeletal systems [21]. RINm5F cells have previously
been described to express Tac1 and to secrete substance P
[47]. Interestingly, substance P has recently been impli-
cated in the autoimmune diabetes of the NOD mouse
model, because expression of the receptor for substance P
(NK-1 receptor) was upregulated in the islets during
development of insulitis [48]. However, preprotachykinin
has been reported to be expressed in rat pancreatic islets
only transiently during development, and the expression
in RINm5F cells may reflect embryonal characteristics of
this cell line [49].
In this study, we took advantage of the RINm5F insuli-
noma cell line as a model for pancreatic β-cells because
cultured clonal cells provide a homogenous, well defined
experimental system for array experiments. RINm5F cells
have frequently been used to characterise the effect of
cytokines on insulin-producing cells (e.g. [36,50]). We
have recently shown that RINm5F cells expressing the
long splicing variant of the leptin receptor (LEPRb) dis-
play the full range of leptin effects relevant for transcrip-
tional regulation (activation of STAT1, STAT3, STAT5,
ERK1/2; [18]. Importantly, most of the leptin-induced
genes detected in the present screen have previously been
identified in microarray analyses of animal models of type
1 or type 2 diabetes or in isolated rat pancreatic β-cells.
Pap and Lcn2 were identified as the genes most strongly
upregulated in islets from diabetic GK rats (a model for
type 2 diabetes) [51]. Expression of Pap, Lcn2, and Sod2
(encoding MnSOD) was found to be increased in a mouse
model of autoimmune diabetes [52]. Transcripts for tPA,
fibrinogen-β and MnSOD were induced by IL-1β in iso-
lated rat βcells [23]. Taken together, these results show
that in RINm5F cells leptin induces a set of genes that is
also expressed in β-cells in models of diabetes and β-cell
destruction.
To sum up, the set of leptin-induced transcripts character-
ised here includes both mRNAs for protective (MnSOD,
PAP1) as well as potentially cytotoxic proteins (lipocalin-
2, preprotachykinin). Other well-characterised proinflam-
matory cytokines, such as the combination of IL-1β and
IFNγ, are also known to induce defence-related genes [23].
Leptin did not induce the same genes as IFNγ, but both
cytokines had the same costimulatory effect on certain IL-
1β-induced transcripts (tPA, lipocalin-2, MnSOD; see Fig-
ure 3). After all, leptin induced caspase activation in
RINm5F cells, strongly suggestive of a pro-apoptotic effect
of leptin. Notably, the leptin concentration applied (100
ng/ml) is within the range of blood levels observed in
obese humans [53]. However, more work is needed to
establish whether the high levels of leptin in obesity have
a protective effect or contribute to islet destruction in vivo.
Finally, we have employed LEPRb tyrosine/phenylalanine
point mutants to provide an initial characterisation of the
signalling pathway responsible for leptin's effect on gene
expression in insulin-producing cells. For all genes under
investigation, the induction by leptin was dependent on
the presence of Tyr1138 which is embedded in a canoni-
cal box3 motif (Tyr-X-X-Gln). This result suggests that the
effect of leptin requires the activation of STAT3 and/or
STAT1. Some of the genes have previously been shown to
be regulated by cytokines that activate STAT3, including
MnSOD, fibrinogen-β, tPA and PAP1. We have previously
identified Pap as a leptin-induced gene in rat PC12 pheo-
chromocytoma cells, and have defined a STAT3-respon-BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
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sive promoter element [25,26]. Lcn2 is also known to be
induced by cytokines that transmit their signal via activa-
tion of the JAK/STAT pathway (IL-9, IL-17, G-CSF). Our
data show that induction of Lcn2 by leptin depends on the
presence of the Tyr1138 in LEPRb, suggesting that activa-
tion of STAT3 and/or STAT1 is required. However, the rat
Lcn2 promoter contains no consensus STAT-binding ele-
ment within the sequence tested in the reporter gene assay
(search of the TRANSFAC database using the TESS soft-
ware [54]). Similarly, no recognisable STAT3-binding site
is present in the rat Tac1  promoter. Considering the
delayed response of both the lipocalin-2 and preprotach-
ykinin-1 mRNA to leptin, it appears likely that regulation
of these genes occurs by an indirect mechanism.
Conclusion
The main result of our study is that leptin induces the
expression of inflammation-related genes in RINm5F
insulinoma cells, of which only PAP was already known as
a leptin target gene. Several of these genes have also been
described to be upregulated in animal models of diabetes
(see discussion section), suggesting that this pattern of
changes in gene expression reflects an inflammatory
response of β-cells. The transcriptional effects of leptin
required a functional box3 motif of the leptin receptor
and are likely mediated via STAT3. Intriguingly, the effect
of leptin on gene expression overlaps partially with that of
IL-1β, a cytokine acting via a completely different signal-
ling pathway, but not with that of IFNγ, which activates
STAT1. The observation that leptin synergises with IL-1β
in caspase 3 induction is consistent with the proposed
function of leptin as a modulator of immune and inflam-
matory responses.
Methods
Cell culture, transient transfections and stably transfected 
cell lines
Rat RINm5F insulinoma cells were grown in RPMI 1640
medium with L-glutamine, 10% (v/v) fetal bovine serum,
100 units/ml penicillin, and 100 mg/ml streptomycin at
37°C and 5% CO2. HIT-T15 hamster insulinoma cells
were cultivated under the same conditions except that 5%
horse serum was added to the medium. Rat PC-12 pheo-
chromocytoma cells stably expressing wild type LEPRb
[25] were grown in DMEM supplemented with 5% fetal
calf serum and 10% horse serum on collagen-coated cul-
ture dishes. To obtain single cells for plating, cells were
passed through a syringe with a 22-gauge needle. HIT-T15
and PC-12 cells were transiently transfected by the poly-
ethylenimine method (Jet-PEI reagent; Polyplus-Transfec-
tion, Illkirch, France). The RINm5F cell line stably
expressing wild type LEPRb has been described previously
[18]. For stable expression of LEPRb tyrosine/phenyla-
lanine mutants, the mutant cDNAs were subcloned from
the pMET7 vector constructs [28] into the retroviral vector
pWZLNeo. These mutant constructs and the correspond-
ing wild type receptor used in the experiments shown in
Figures 4, 5, 6 contain a C-terminal myc-tag. Confluent
RINm5F cells were infected with pWZL-Neo viruses, and
infected cells were selected with geneticine sulphate
(G418; 1 mg/ml) as described before [18]. Cell surface
expression of the different LEPRb constructs on RINm5F
cells was measured using a mouse leptin-secreted alkaline
phosphatase chimeric protein as described [28]. Murine
leptin was purchased from PeproTech (London, UK),
human IL-1β from Roche Diagnostics (Mannheim, Ger-
many), and rat IFNγ from Serotec (Düsseldorf, Germany).
Isolation of RNA and differential hybridisation of high 
density cDNA filter arrays
RINm5F-LepRb cells grown to 80% confluence were incu-
bated in serum-free medium for 20 h before they were
stimulated with murine leptin (100 ng/ml; PeproTech,
London, UK) or left unstimulated for 16 h. Total RNA was
isolated using the RNeasy Midi Kit (Qiagen, Hilden, Ger-
many), and poly-A+-RNA was prepared using oligo-
(dT)30-coupled paramagnetic beads (Chemagen, Baes-
weiler, Germany). Complex cDNA probe was generated
from 500 ng of poly-A+-RNA by reverse transcription in
the presence of 7.5 MBq [α-33P]-dCTP (111 TBq/mmol
Hartmann Analytics, Braunschweig, Germany) according
to the protocol suggested by the manufacturer of the
cDNA array (RZPD Berlin, Germany). The 33P-labelled
single-stranded cDNA was hybridised to high density filter
arrays that contained double-spotted, PCR-amplified
cDNA inserts of the rat UniGene cDNA library (library
953, RZPD Berlin). This library comprises a set of 27,648
non-redundant rat cDNA clones provided by Bento Soares
(University of Iowa). The filter were washed at high strin-
gency (final wash in 150 mM NaCl/15 mM Na-citrate pH
7.0/0.1% SDS at 65°C) and exposed for 72 hours to a
phosphor storage screen (Fujifilm Imaging Plate BAS-
MS2325, Fuji Photo Film, Japan). For probe removal, the
filter was doused with boiling 0.1% SDS, 5 mM phos-
phate buffer (ph 7.6) and left at room temperature under
continuous agitation. This procedure was repeated and
probe removal confirmed by exposure of an phosphor
storage screen before rehybridization.
Analysis of array data
Signal intensities were evaluated using the AIDA™ soft-
ware (AIDA Advanced Image Data Analyzer and AIDA
Array Compare V 3.0; Raytest, Straubenhardt, Germany)
as follows: integrated intensity values were determined for
each spot and means of the two spots containing the same
cDNA probe were calculated. For background correction,
the signal intensity of the space between the spots was
subtracted. To normalise for global intensity differences
between the data sets, intensity values were divided by the
intensity value of the spots containing β-actin cDNA.BMC Molecular Biology 2007, 8:41 http://www.biomedcentral.com/1471-2199/8/41
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mRNA levels of β-actin were confirmed by Northern blot
analysis to be unaffected by leptin treatment of RINm5F
cells (data not shown). Only transcripts with an absolute
signal intensity ≥ 1.0 that showed a ≥ 2.5-fold increase
were considered relevant. The data presented in Table 1
and and Additional file 1 were obtained by successive
hybridisation of the same filter array with the two com-
plex cDNA probes derived from one experiment. Con-
firmatory Northern blot hybridisations (last column of
table in Additional file 1) were done with RNA samples
from independent experiments. Potentially interesting
transcripts were arbitrarily selected for further analysis.
Northern blot analysis
Samples (10 µg) of total RNA were separated by denatur-
ing formaldehyde electrophoresis on 1% (w/v) agarose
gels and transferred by capillary blot onto positively
charged nylon membranes (Hybond N+; Amersham,
Freiburg, Germany). Labelled probes were generated from
the inserts of cDNA clones listed in Table 1 by random oli-
gonucleotide priming. Murine cDNA clones were used to
generate the probes for iNOS (inducible nitric oxide syn-
thase; IMAGE clone 3583251, GenBank acc. No.
BE372884) and IRF-1 (interferon regulatory factor 1,
IMAGE clone 3600525, GenBank acc. No. BC003821).
Blots were re-hybridised with other cDNA probes after
probe removal by incubation with 0.5% SDS at 100°C.
Western blot analysis
Stably transfected RINm5F cells were incubated in serum-
free medium for 18–22 h before cytokines (100 ng/ml
leptin, 50 u/ml IL-1β, or 25 ng/ml IFNγ) were added for
15 min. Cells were washed with phosphate buffered saline
and lysed in 1% SDS, 20 mM Tris-Cl pH 7.4 in a boiling
water bath for 5 min. Total cellular lysates were separated
by SDS-PAGE (8% gels), blotted on-to nitrocellulose, and
phosphorylation of specific proteins was analysed using
the following antibodies (Cell Signaling Technology, Bev-
erly, MA): anti-p(Y701)-STAT1, anti-p(Y705)-STAT3, anti-
p(Y694/699)-STAT5A/B, and anti-pT/pY-ERK1/2. Horse-
radish peroxidase-labelled anti-rabbit IgG (IgG-POD
from Pierce Chemical Co., Rockford, IL) was used as the
second antibody. Blots were re-used after stripping the pri-
mary antibody by incubation at room temperature for
20–30 min in 2% SDS, 50mM Tris-Cl, 150 mM NaCl,
pH7.4 in the presence of 100 mM 2 mercaptoethanol.
Reporter gene assays
A luciferase reporter construct containing the promoter
region (-865 to +447; pSUB201-LPPT) of the rat prepro-
tachykinin A gene (Tac1) was kindly provided by John
Quinn, University of Liverpool, UK [55,56]. A 976-bp
fragment of the rat lipocalin-2 (Lcn2) promoter region (-
930 to +46, the first nucleotide of the cDNA sequence
with GenBank acc. No. X13296 was defined as +1) was
amplified with primers rLcn2-930for (5'-ATAGGTACCG-
GATGCCTTTTCAAGGGAGG-3') and rLcn2-Exon1rev (5'-
GACACCCAGGCCCATGGTTTCAGC-3') from rat
genomic DNA. The PCR product was cloned into the
pGL3basic vector (Promega, Madison, WI) using the engi-
neered KpnI site in the upstream primer and an endog-
enous NcoI site at the initiator codon, resulting in pGL3-
rLcn2(-930). DNA sequencing confirmed the identity of
the PCR product and revealed a polymorphism in the rat
Lcn2 promoter: a dinucleotide repeat (at -846 to -784) in
our construct (from RINm5F genomic DNA) contained
two more CA dinucleotides than the sequence (from the
Sprague Dawley rat strain) available at the Genome
Browser Gateway [57]. This polymorphic microsatellite
has previously been used to map the rat Lcn2 gene [58]
HIT-T15 cells were seeded in six-well plates (3.3–4.0 × 105
cells per well) and transfected with 0.5 µg of pSUB201-
LPPT or pGL3- rLcn2(-930), along with 1.0 µg of the β-
galactosidase reporter control plasmid pSVβ-gal
(Promega) and 0.3 µg of the pMET7-LEPRb expression
plasmids [28]. 24 h or 48 h after transfection, the cells
were stimulated with 100 ng/ml leptin for 22 hours in
serum-free medium. Luciferase activities were determined
from duplicate wells with the help of a commercial kit
(Promega) and data were normalised to β-galactosidase
activities. For assays of PC-12-L8 cells, cells from one 80
cm2-flask were seeded into 12 wells of collagen-coated six-
well plates and transfected with reporter gene plasmids as
above. Fresh serum-containing medium was added the
day after transfection, and cells were treated with leptin
(100 ng/ml) and/or forskolin (10 µM) 24 h later. To avoid
effects of differentiation, care was taken that the cells
never reached confluence.
Assay of caspase activity
RINm5F cells were seeded in a white, non-translucent 96-
well plate (10,000 cells per well). The following day, cells
were supplied with fresh medium and stimulated with
cytokines as indicated. After incubation for 72 h, DEVD-
directed protease activity was determined from triplicate
wells with the help of the Caspase-Glo™ 3/7 Assay
(Promega) which detects caspase activity based on the
sequence-specific cleavage of a proluminescent caspase-3/
7 DEVD-aminoluciferin substrate. The data were evalu-
ated for statistical significance with the two-tailed Stu-
dent's  t  test, and the differences were considered
significant at P < 0.05.
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